Department of Intensive Care and Anaesthesiology, Rome, Italy.
Department of Intensive Care and Anaesthesiology, Rome, Italy.
Clin Microbiol Infect. 2016 May;22(5):456.e7-456.e13. doi: 10.1016/j.cmi.2015.12.015. Epub 2015 Dec 23.
A relationship between vitamin D status and mortality in patients in intensive care units (ICU) has been documented. The present study aims to describe the clinical profile and sepsis-related outcome of critically ill septic patients with extremely low (<7 ng/mL) vitamin D levels at ICU admission. We conducted an observational study in the ICU of a teaching hospital including all patients admitted with severe sepsis/septic shock and undergoing 25-hydroxyvitamin D (25(OH)D) testing within the first 24 hours from admission. We studied 107 patients over 12 months. At ICU admission vitamin D deficiency (≤20 ng/mL) was observed in 93.5% of the patients: 57 (53.3%) showed levels <7 ng/mL. As primary outcome, sepsis-related mortality rate was higher in patients with vitamin D levels <7 ng/mL (50.9% versus 26%). Multivariate regression analysis showed that vitamin D concentration <7 ng/mL on ICU admission (p 0.01) and higher mean SAPS II (p <0.01) score were independent predictors of sepsis-related mortality. Patients with very low vitamin D levels suffered higher rate of microbiologically confirmed infections but a lower percentage of microbiological eradication with respect to patients whose values were >7 ng/mL (80.7% versus 58%, p 0.02; 35.3% versus 68%; p 0.03, respectively). Post hoc analysis showed that, in the extremely low vitamin D group, the 52 patients with pneumonia showed a longer duration of mechanical ventilation (9 days (3.75-12.5 days) versus 4 days (2-9 days), p 0.04) and the 66 with septic shock needed vasopressor support for a longer period of time (7 days (4-10 days) versus 4 days (2-7.25 days), p 0.02). Our results suggest that in critical septic patients extremely low vitamin D levels on admission may be a major determinant of clinical outcome. Benefits of vitamin D replacement therapy in this population should be elucidated.
已有文献证明,维生素 D 状态与重症监护病房(ICU)患者的死亡率之间存在关联。本研究旨在描述 ICU 入院时维生素 D 水平极低(<7ng/mL)的危重症脓毒症患者的临床特征和与脓毒症相关的结局。我们在一家教学医院的 ICU 进行了一项观察性研究,纳入了所有入院时患有严重脓毒症/脓毒性休克并在入院后 24 小时内进行 25-羟维生素 D(25(OH)D)检测的患者。我们在 12 个月内研究了 107 名患者。在 ICU 入院时,93.5%的患者存在维生素 D 缺乏症(≤20ng/mL):57 名患者(53.3%)的维生素 D 水平<7ng/mL。作为主要结局,维生素 D 水平<7ng/mL 的患者脓毒症相关死亡率更高(50.9% vs. 26%)。多变量回归分析显示,ICU 入院时维生素 D 浓度<7ng/mL(p<0.01)和较高的平均 SAPS II 评分(p<0.01)是与脓毒症相关的死亡率的独立预测因素。维生素 D 水平极低的患者发生微生物学确诊感染的比率较高,但与维生素 D 值>7ng/mL 的患者相比,微生物学清除率较低(80.7% vs. 58%,p<0.02;35.3% vs. 68%,p<0.03)。事后分析显示,在极低维生素 D 组中,52 名肺炎患者的机械通气时间更长(9 天(3.75-12.5 天) vs. 4 天(2-9 天),p<0.04),66 名脓毒性休克患者需要血管加压素支持的时间更长(7 天(4-10 天) vs. 4 天(2-7.25 天),p<0.02)。我们的结果表明,在危重症脓毒症患者中,入院时极低的维生素 D 水平可能是临床结局的主要决定因素。应阐明该人群中维生素 D 替代治疗的益处。